CFD 属于复杂的高风险金融工具，其杠杆作用可能导致投资者迅速亏损。 84% 的散户投资者因进行 CFD 交易遭受资金损失。 请您谨慎考虑自己是否了解 CFD 操作，以及是否能够接受高额亏损的风险。
US 简体中文
國家 • United States
    實體 • The products and services listed on this website are not available in this location.
    English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文

    交易 Virpax Pharmaceuticals, Inc. - VRPX CFD

    0.77
    0%
    • 概括
    • 历史数据
    • 活动
    • 收入报表
    • 资产负债表
    • 现金流
    • 所有权
    交易条件
    价差 0.08
    多头隔夜费

    Long position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 -0.025457 %
    Charges from borrowed part ($-1.02)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		-0.025457%
    空头隔夜费

    Short position overnight fee

    Margin. Your investment $1,000.00
    隔夜费用 0.003235 %
    Charges from borrowed part ($0.13)
    Trade size with leverage ~ $5,000.00
    Money from leverage ~ $4,000.00
    前往平台
    		0.003235%
    隔夜费时间 21:00 (UTC)
    最小交易量 1
    货币 USD
    保证金 20%
    上市交易所 United States of America
    交易费 0%

    *Information provided by Capital.com

    关键数据
    前收盘价* 0.77
    开仓* 0.77
    1 年变化* -40.77%
    日范围* 0.74 - 0.77
    52 周范围 0.61-1.83
    平均交易量（10 天） 16.57K
    平均交易量（3 个月) 370.27K
    市值 9.26M
    市盈率 -100.00K
    流通股 11.71M
    收入 N/A
    EPS -1.54
    股息（收益率 %） N/A
    贝塔 -100.00K
    下一个财报发布日期 N/A

    所有数据都是由Refinitiv提供的， 除了标有星号的数据， 这是*由 Capital.com 提供的数据

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date 平仓 Change Change (%) 開倉 High Low
    May 26, 2023 0.77 -0.02 -2.53% 0.79 0.79 0.74
    May 25, 2023 0.77 0.00 0.00% 0.77 0.78 0.76
    May 24, 2023 0.77 0.01 1.32% 0.76 0.80 0.76
    May 23, 2023 0.78 -0.03 -3.70% 0.81 0.81 0.77
    May 22, 2023 0.73 0.06 8.96% 0.67 0.73 0.67
    May 19, 2023 0.78 -0.01 -1.27% 0.79 0.80 0.77
    May 18, 2023 0.79 -0.02 -2.47% 0.81 0.81 0.76
    May 17, 2023 0.78 0.02 2.63% 0.76 0.84 0.76
    May 16, 2023 0.76 -0.04 -5.00% 0.80 0.80 0.74
    May 15, 2023 0.84 -0.02 -2.33% 0.86 0.86 0.82
    May 12, 2023 0.83 0.06 7.79% 0.77 0.86 0.77
    May 11, 2023 0.83 0.07 9.21% 0.76 0.85 0.76
    May 10, 2023 0.76 -0.01 -1.30% 0.77 0.77 0.74
    May 9, 2023 0.73 -0.04 -5.19% 0.77 0.77 0.70
    May 8, 2023 0.71 0.02 2.90% 0.69 0.76 0.69
    May 5, 2023 0.70 0.01 1.45% 0.69 0.71 0.65
    May 4, 2023 0.65 -0.02 -2.99% 0.67 0.68 0.65
    May 3, 2023 0.64 0.03 4.92% 0.61 0.64 0.61
    May 2, 2023 0.62 -0.04 -6.06% 0.66 0.66 0.62
    May 1, 2023 0.66 0.02 3.13% 0.64 0.67 0.64

    Virpax Pharmaceuticals, Inc. Events

    时间（协调世界时） (UTC) 国家/地区 事件
    No events scheduled
    查看所有活動
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    总收入 0 0 0 0 0
    总营业费用 21.8451 12.0255 4.19572 3.18187 2.62596
    销售/一般/行政费用，总计 11.0825 7.18639 2.9041 2.55913 1.48379
    研究与开发 10.7627 4.83912 1.29162 0.62274 1.14218
    营业收入 -21.8451 -12.0255 -4.19572 -3.18187 -2.62596
    利息收入（费用），非经营净值 0 -0.09282 -0.14793 -0.12464 -0.01498
    税前净收入 -21.6507 -12.0561 -4.33965 -3.30651 -2.64094
    税后净收入 -21.6507 -12.0561 -4.33965 -3.30651 -2.64094
    未计算非常项目前的净收益 -21.6507 -12.0561 -4.33965 -3.30651 -2.64094
    净收入 -21.6507 -12.0561 -4.33965 -3.30651 -2.64094
    普通股股东可获收益 (不含非经常性项目) -21.6507 -12.0561 -4.33965 -3.30651 -2.64094
    普通股股东可获收益 (含非經常性項目) -21.6507 -12.0561 -4.33965 -3.30651 -2.64094
    摊薄净收入 -21.6507 -12.0561 -4.33965 -3.30651 -2.64094
    摊薄后加权平均股 11.7122 6.67727 4.94515 4.94515 4.94515
    扣除特别项目的每股摊薄盈利 -1.84856 -1.80554 -0.87756 -0.66864 -0.53405
    Dividends per Share - Common Stock Primary Issue 0 0 0
    每股正常摊薄盈利 -1.84856 -1.80554 -0.87756 -0.66864 -0.53405
    其他，净值 0.19441 0.06226 0.004
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    总收入 0 0 0 0 0
    总营业费用 1.65107 3.10208 7.71514 5.90409 5.12382
    销售/一般/行政费用，总计 0.41545 1.74439 4.91004 2.64562 1.78241
    研究与开发 1.23561 1.35769 2.8051 3.25847 3.34141
    营业收入 -1.65107 -3.10208 -7.71514 -5.90409 -5.12382
    利息收入（费用），非经营净值 0 0 0 0
    税前净收入 -1.52053 -2.98711 -7.64189 -5.88472 -5.137
    税后净收入 -1.52053 -2.98711 -7.64189 -5.88472 -5.137
    未计算非常项目前的净收益 -1.52053 -2.98711 -7.64189 -5.88472 -5.137
    净收入 -1.52053 -2.98711 -7.64189 -5.88472 -5.137
    普通股股东可获收益 (不含非经常性项目) -1.52053 -2.98711 -7.64189 -5.88472 -5.137
    普通股股东可获收益 (含非經常性項目) -1.52053 -2.98711 -7.64189 -5.88472 -5.137
    摊薄净收入 -1.52053 -2.98711 -7.64189 -5.88472 -5.137
    摊薄后加权平均股 11.7143 11.7139 11.7134 11.7128 11.7087
    扣除特别项目的每股摊薄盈利 -0.1298 -0.25501 -0.65241 -0.50242 -0.43873
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    每股正常摊薄盈利 -0.1298 -0.25501 -0.65241 -0.50242 -0.43873
    其他，净值 0.13053 0.11497 0.07325 0.01937 -0.01318
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    流动资产总额 19.6737 39.5724 0.07307 0.04672 0.0615
    现金和短期投资 18.9953 36.842 0.0548 0.04154 0.04837
    Cash 18.9953 36.842 0.0548 0.04154 0.04837
    应收账款总额，净额 0 0.00139 0
    Accounts Receivable - Trade, Net 0 0.00139 0
    Prepaid Expenses 0.65302 2.61894 0.00879 0.0038 0.00263
    Other Current Assets, Total 0.02534 0.1115 0.00948 0 0.0105
    Total Assets 19.6737 39.5724 0.46541 0.04672 0.0615
    Total Current Liabilities 3.09459 2.08769 3.65991 2.77899 1.25422
    Accrued Expenses 0.65477 0.62728 0.27 0.81916 0.30572
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 0.54399 1.26452 0.5
    Other Current Liabilities, Total 2.43983 1.46041 2.84592 0.69531 0.44851
    Total Liabilities 3.09459 2.08769 4.6815 2.77899 1.25422
    Total Long Term Debt 0 0 1.02159 0 0
    Total Equity 16.5791 37.4847 -4.2161 -2.73228 -1.19272
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.00012 0.00012 0.00003 0.00015 0.00014
    Additional Paid-In Capital 60.9336 60.1885 6.43172 3.57577 1.80881
    Retained Earnings (Accumulated Deficit) -44.3546 -22.7039 -10.6478 -6.30819 -3.00168
    Total Liabilities & Shareholders’ Equity 19.6737 39.5724 0.46541 0.04672 0.0615
    Total Common Shares Outstanding 11.7143 11.7149 4.94515 4.94515 4.94515
    Other Long Term Assets, Total 0 0.39234
    Long Term Debt 0 1.02159
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    流动资产总额 18.4933 19.6737 23.6358 29.4024 34.746
    现金和短期投资 16.9869 18.9953 20.5626 26.0611 30.7971
    Cash 16.9869 18.9953 20.5626 26.0611 30.7971
    Prepaid Expenses 1.47637 0.65302 3.04688 3.33408 3.81772
    Other Current Assets, Total 0.03006 0.02534 0.02627 0.00723 0.13112
    Total Assets 18.4933 19.6737 23.6358 29.4024 34.746
    Other Long Term Assets, Total
    Total Current Liabilities 3.29424 3.09459 4.20787 2.48337 2.18689
    Accrued Expenses 0.16409 0.65477 0.31123 0.23561 0.15593
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases
    Other Current Liabilities, Total 3.13015 2.43983 1.89664 2.24776 2.03096
    Total Liabilities 3.29424 3.09459 4.20787 2.48337 2.18689
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt
    Total Equity 15.1991 16.5791 19.4279 26.9191 32.5591
    Preferred Stock - Non Redeemable, Net 0 0
    Common Stock 0.00012 0.00012 0.00012 0.00012 0.00012
    Additional Paid-In Capital 61.0742 60.9336 60.7953 60.6446 60.3999
    Retained Earnings (Accumulated Deficit) -45.8752 -44.3546 -41.3675 -33.7256 -27.8409
    Total Liabilities & Shareholders’ Equity 18.4933 19.6737 23.6358 29.4024 34.746
    Total Common Shares Outstanding 11.7143 11.7143 11.7144 11.7146 11.7147
    Payable/Accrued 2
    • 年度
    • 每季度
    2022 2021 2020 2019 2018
    净收入/起跑线 -21.6507 -12.0561 -4.33965 -3.30651 -2.64094
    经营活动产生的现金 -17.8467 -14.5426 -1.38486 -1.13183 -1.79964
    非现金物品 0.74503 0.91242 1.62686 1.24279 0.39993
    Cash Taxes Paid 0 0 0 0 0
    已付现金利息 0 0.36282 0 0 0
    营运资金的变化 3.05898 -3.39895 1.32793 0.93189 0.44137
    融资活动产生的现金 0 51.3298 1.39812 1.125 1.67477
    股票的发行（报废），净额 0 58.02 1.3769 0.625 1.12
    债务的发行（退还），净额 0 -1.50376 0.0721 0.5 0.55477
    现金净变化 -17.8467 36.7872 0.01326 -0.00683 -0.12487
    融资现金流项目 0 -5.18645 -0.05088
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -1.52053 -21.6507 -18.6636 -11.0217 -5.137
    Cash From Operating Activities -2.00837 -17.8467 -16.2794 -10.7809 -6.04486
    Non-Cash Items 0.14058 0.74503 0.60676 0.45604 0.21134
    Cash Taxes Paid 0 0 0 0 0
    Cash Interest Paid 0 0 0 0 0
    Changes in Working Capital -0.62842 3.05898 1.77747 -0.21518 -1.1192
    Cash From Financing Activities 0 0 0 0
    Financing Cash Flow Items 0 0 0 0
    Issuance (Retirement) of Stock, Net 0 0 0 0
    Issuance (Retirement) of Debt, Net 0 0 0 0
    Net Change in Cash -2.00837 -17.8467 -16.2794 -10.7809 -6.04486
    投资者名称 投资者类型 流通股百分比 持有股份 股份变动 持有日期 换手率
    Virpax Pharmaceuticals LLC Corporation 23.3086 2730438 0 2023-03-22 LOW
    Sabby Management, LLC Investment Advisor/Hedge Fund 5.988 701455 -286710 2023-03-31 LOW
    Mack (Anthony P.) Individual Investor 2.156 252562 0 2023-03-22 LOW
    PNC Investments LLC Investment Advisor 0.8611 100875 0 2023-03-31 LOW
    Renaissance Technologies LLC Hedge Fund 0.8135 95300 -900 2023-03-31 HIGH
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5637 66038 0 2023-03-31 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 0.5561 65145 -112591 2023-03-31 LOW
    Belpointe Asset Management LLC Investment Advisor/Hedge Fund 0.1626 19045 0 2023-03-31 MED
    Warberg Asset Management LLC Hedge Fund 0.1452 17012 0 2023-03-31 HIGH
    Cambridge Investment Research Advisors, Inc. Investment Advisor 0.1372 16070 -400 2023-03-31 LOW
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1299 15221 0 2023-03-31 LOW
    Quantum Private Wealth, LLC Investment Advisor 0.0854 10000 0 2023-03-31 LOW
    Sendrow (Jerrold B) Individual Investor 0.0769 9006 0 2023-03-22 LOW
    Floyd (Eric) Individual Investor 0.0685 8023 5 2023-03-22 LOW
    Gudin (Jeffrey) Individual Investor 0.0647 7584 0 2023-03-22 LOW
    Tower Research Capital LLC Hedge Fund 0.0466 5463 333 2023-03-31 HIGH
    Bruce (Gerald W) Individual Investor 0.0345 4045 0 2023-03-22 LOW
    Advisor Group, Inc Investment Advisor 0.0051 600 0 2023-03-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 0.004 464 0 2023-03-31 LOW
    Morgan Stanley Smith Barney LLC Investment Advisor 0.0013 150 -916 2023-03-31 LOW

    为什么选择 Capital.com？让我们的数字来说话。

    Capital.com Group

    530K+

    交易者

    87K+

    每月活跃客户

    $46M+

    每月投资额

    $31M+

    每月提取金额

    交易计算器

    如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。

    交易佣金
    0
    • 1:1
    杠杆
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    投资
    交易规模（杠杆 x 投资）：
    開倉

    平仓

    做空 做多
    過去的表現並不是未來結果的可靠指標
    盈利/盈利/亏损

    Virpax Pharmaceuticals, Inc. Company profile

    关于 Virpax Pharmaceuticals Inc

    Virpax Pharmaceuticals, Inc.是一家处于临床前阶段的制药公司。 该公司专注于开发新型和专有的药物输送系统。 公司正在开发的药物输送系统和药物释放技术主要是为了推进非阿片类和非成瘾性疼痛管理治疗和中枢神经系统（CNS）疾病的治疗，以提高患者的生活质量。 公司的产品组合包括候选产品，如Epoladerm、Probudur、Envelta、PES200、AnQlar和VRP324。 Epoladerm是一种每日外用的非甾体抗炎药（NSAID），用于治疗膝关节慢性骨关节炎。 PES200能够将一种代谢不稳定的肽类药物（Enkephalin）送入大脑，用于治疗创伤后应激障碍。 AnQlar在体内研究中也显示了脑部病毒负荷的减少。 VRP324正在开发中，用于治疗两岁及以上患者的Dravet和Lennox-Gastaut综合症相关的癫痫发作。

    Industry: Biotechnology & Medical Research (NEC)

    1055 Westlakes Drive, Suite 300
    BERWYN
    PENNSYLVANIA 19312
    US

    收入报表

    • Annual
    • Quarterly

    人们也观看

    Oil - Crude

    72.40 Price
    -0.930% 1D Chg, %
    多头隔夜费 -0.0146%
    空头隔夜费 -0.0073%
    隔夜费时间 21:00 (UTC)
    价差 0.03

    Gold

    1,939.69 Price
    -0.200% 1D Chg, %
    多头隔夜费 -0.0184%
    空头隔夜费 0.0102%
    隔夜费时间 21:00 (UTC)
    价差 0.30

    XRP/USD

    0.50 Price
    +2.330% 1D Chg, %
    多头隔夜费 -0.0753%
    空头隔夜费 0.0069%
    隔夜费时间 21:00 (UTC)
    价差 0.00385

    US100

    14,355.50 Price
    -0.080% 1D Chg, %
    多头隔夜费 -0.0255%
    空头隔夜费 0.0032%
    隔夜费时间 21:00 (UTC)
    价差 1.8

    还在找一位您可以信任的经纪商吗？

    加入成为全球530,000万多名交易者的一份子，选择利用Capital.com进行交易吧。

    1. 创建和验证您的账户 2. 进行存款 3. 找到适合您的交易